Evaluation of the efficacy and safety of Artemether+Lumefantrine (Coartem) with low-dose Primaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in three sites of Savanakhet, Champasack, and Salavanh province, Lao PDR.

Status: Not yet recruiting

Phase of Trial: Phase IV

Latest Information Update: 06 Mar 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Artemether/lumefantrine (Primary) ; Primaquine
Indications Falciparum malaria; Vivax malaria
Focus Therapeutic Use

Most Recent Events

05 Mar 2020 Planned End Date changed from 31 Jan 2020 to 2 Feb 2021.
05 Mar 2020 Planned initiation date changed from 1 Apr 2019 to 2 Apr 2020.
26 Mar 2019 According to Australian New Zealand Clinical Trials Registry, the anticipated date for last participant enrollment is 12/31/2019.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight